MMRGlobal to Lead International Revenue Push at HIMSS 2012

LOS ANGELES, CA--(Marketwire - Feb 6, 2012) - MMRGlobal, Inc. (OTCBB: MMRF) ("MMR"), a leading provider of Personal Health Records ("PHR"), MyEsafeDepositBox storage solutions and electronic document management and imaging systems for healthcare professionals, today announced its global lineup at the annual HIMSS Conference and Exhibition, February 21-24, 2012, in Booth #2062. The Company will be joined in Las Vegas at the Health IT trade show by international strategic partners from Australia, Jacques Blandin, Chairman and Founder of VisiInc, PLC, and from China, Luo Jianhui, Vice President and Chairman of Unisoft Group, Unis-Tonghe Technology (Zhengzhou) Co., Ltd. Alcatel-Lucent, a majority owner of Shanghai Bell, will also support MMR with the Company's Unis-Tonghe relationship in China. MMR U.S. strategic partner Interbit Data will demonstrate a customized version of MMRPatientView, developed exclusively for MEDITECH's Electronic Medical Record ("EMR") systems. Also present in the booth will be strategic development partner UST Global who is connecting MMR to UST EMR solutions.

The Company will also demonstrate how its patented MyMedicalRecords Personal Health Record connects to telemedicine solutions from Alcatel-Lucent and pharmacy and lab data reporting systems through 4medica, both companies also exhibitors at HIMSS. The MMR booth will be designed around the Company's theme, "The Future of Your Health at Work Today," and as such, will feature its newly developed mobile and tablet Personal Health Record and emergency portals along with the latest versions of MMRPro. MMRPro is a high-volume document imaging and scanning solution designed to eliminate paper by digitizing the offices of healthcare professionals. The Company will feature its latest versions of MMRPro on both Kodak and Fujitsu scanning solutions at HIMSS. The combination of features and benefits makes MMR products and services the most comprehensive Personal Health Record and electronic document management system in the market today.

"While the use of EMRs grows worldwide, the need to convert existing plain paper medical records also increases. MMRPro deals with the problems of digitally converting existing paper files when an EMR is being installed and manages the ongoing process of digitizing new patient records as they come into the office after an EMR is up and running. Since the launch of MMRPro, the system has securely and cost effectively scanned, processed and stored millions of pages of patient records, receiving more than 1,000 pages per day from the average MMRPro physician practice. Based on the success in the U.S., we anticipate taking MMRPro global starting with our Australian and Chinese partners, which can represent significant revenues here and abroad," said Robert H. Lorsch, Chairman and CEO of MMRGlobal, Inc.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR"), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. and its products, visit www.mmrglobal.com.

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Factors that could cause or contribute to such differences include, but are not limited to, the risk the Company's products are not adopted or viewed favorably by the health care community; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; ability to identify and integrate acquisitions; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; acceptance of the Company's marketing and promotional campaigns; risks related to a security breach by third parties; maintaining, developing and defending our intellectual property rights including those pertaining to our biotechnology assets; risks associated with recruitment and retention of key personnel; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. Additionally, we are a developing early-stage company and many variables can affect revenues and/or projections, including factors out of our control. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.